3D bioprinted osteosarcoma model for experimental boron neutron capture therapy ( BNCT ) applications: Preliminary assessment
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2023
DOI: 10.1002/jbm.b.35255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2023. Verfasst von Elena Delgrosso und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Surgical Sciences; integrated unit of experimental surgery, advanced microsurgery and regenerative medicine, University of Pav…. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteosarcoma is the most frequently primary malignant bone tumor characterized by infiltrative growth responsible for relapses and metastases. Treatment options are limited, and a new therapeutic option is required. Boron neutron capture therapy (BNCT) is an experimental alternative radiotherapy able to kill infiltrative tumor cells spearing surrounding healthy tissues. BNCT studies are performed on 2D in vitro models that are not able to reproduce pathological tumor tissue organization or on in vivo animal models that are expensive, time‐consuming and must follow the 3R's principles. A 3D in vitro model is a solution to better recapitulate the complexity of solid tumors meanwhile limiting the animal's use. Objective of this study is to optimize the technical assessment for developing a 3D in vitro osteosarcoma model as a platform for BNCT studies: printing protocol, biomaterial selection, cell density, and crosslinking process. The best parameters that allow a fully colonized 3D bioprinted construct by rat osteosarcoma cell line UMR‐106 are 6 × 10 6 cells/ml of hydrogel and 1% CaCl 2 as a crosslinking agent. The proposed model could be an alternative or a parallel approach to 2D in vitro culture and in vivo animal models for BNCT experimental study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Surgical Sciences; integrated unit of experimental surgery, advanced microsurgery and regenerative medicine, University of Pavia, Pavia, Italy.
- Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
- National Institute of Nuclear Physics, Unit of Pavia, Pavia, Italy.
- Department of Public Health, Experimental and Forensic Medicine, Histology and Embryology Unit, University of Pavia, Pavia, Italy.
- Department of Physics, University of Pavia, Pavia, Italy.
- IRCCS S. Matteo Hospital, Pavia, Italy.
ORCID-Profile: Elena Delgrosso
Zitieren
APA
Delgrosso, E., Scocozza, F., Cansolino, L., Riva, F., Conti, M., Loi, G., Auricchio, F., Postuma, I., Bortolussi, S., Cobianchi, L., & Ferrari, C. (2023). 3D bioprinted osteosarcoma model for experimental boron neutron capture therapy ( BNCT ) applications: Preliminary assessment. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35255
Vancouver
Delgrosso E, Scocozza F, Cansolino L, Riva F, Conti M, Loi G, et al. 3D bioprinted osteosarcoma model for experimental boron neutron capture therapy ( BNCT ) applications: Preliminary assessment. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2023. doi:10.1002/jbm.b.35255
BibTeX
@article{Delgrosso2023,
author = {Delgrosso, Elena and Scocozza, Franca and Cansolino, Laura and Riva, Federica and Conti, Michele and Loi, Giada and Auricchio, Ferdinando and Postuma, Ian and Bortolussi, Silva and Cobianchi, Lorenzo and Ferrari, Cinzia},
title = {3D bioprinted osteosarcoma model for experimental boron neutron capture therapy ( BNCT ) applications: Preliminary assessment},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2023},
doi = {10.1002/jbm.b.35255}
}
EUVIMED